1. Home
  2. List
Reference Patent

Reference - List

  • 11 Hits
  • Search Condition : Filter (MeSH = MutL Protein Homolog 1)
Species Resource Title
Arabidopsis / Cultured plant cells, genes pda02005 An easy protocol for studying chromatin and recombination protein dynamics during Arabidopsis thaliana meiosis: immunodetection of cohesins, histones and MLH1.
Human and Animal Cells MKN1(RCB1003) , MKN7(RCB0999) ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability.
Human and Animal Cells TGBC2TKB(RCB1130) The effect of o6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair gene (hMLH1) status on the sensitivity to alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea(ACNU) in gallbladder carcinoma cells.
Human and Animal Cells TGBC2TKB(RCB1130) Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest.
Human and Animal Cells MKN28(RCB1000) , MKN45(RCB1001) Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues.
Human and Animal Cells HBL-100(RCB0460) Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas.
Human and Animal Cells HHUA(RCB0658) CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.
DNA material , Human and Animal Cells CSII-EF-MCS (RDB04378) , PANC-1 , KP-4 , MIAPaCa2 GLI1 interferes with the DNA mismatch repair system in pancreatic cancer through BHLHE41-mediated suppression of MLH1.
Human and Animal Cells MKN28(RCB1000) , MKN45(RCB1001) Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
DNA material pSVtsA58 ori (-) (RDB01126) Roles of MGMT and MLH1 proteins in alkylation-induced apoptosis and mutagenesis.
DNA material pSVtsA58 ori (-) (RDB01126) Different initial steps of apoptosis induced by two types of antineoplastic drugs.